Downloadable Slidesets

Share

Program Content

Activities

  • ND AML Tx Without Targets
    Selecting Therapy for AML Without Predictive Biomarkers or Therapeutically Actionable Genomic or Molecular Alterations
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • ND AML Tx With Targets
    Selecting Therapy for AML With Predictive Biomarkers or Therapeutically Actionable Genomic or Molecular Alterations
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • MRD and Maintenance in AML
    New and Novel Advances in AML Therapeutics
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2020

    Expires: December 03, 2021

  • <i>EP</i>: AML Treatment Paradigm
    ExpressPoints: Using Available Evidence and Guidelines for Managing an Evolving AML Treatment Paradigm
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2020

    Expires: December 16, 2021

Faculty

cover img faculity

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Alice Mims, MD, MSCR

Associate Professor
Division of Hematology
Department of Internal Medicine
The Ohio State University
Columbus, Ohio

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from

Agios Pharmaceuticals

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.